RECORD OF PROCEEDINGS
PHYSICAL DISABILITY BOARD OF REVIEW
NAME: XXXXXXXXXXXXX BRANCH OF SERVICE: ARMY
DATE OF PLACEMENT ON TDRL: 20021011
CASE NUMBER: PD1200469
BOARD DATE: 20121114 DATE OF PERMANENT SEPARATION DATE: 20031112
SUMMARY OF CASE: Data extracted from the available evidence of record reflects that this
covered individual (CI) was an active duty Major/O4, (67C/Senior Preventive Medicine Officer)
medically separated for asthma. The CI had a history of symptoms consistent with asthma for
over ten years. Prior to November 2001, his asthma was easily controlled with daily
medications and he experienced no respiratory problems when donning protective equipment.
In October 2001, he failed a physical fitness test due “asthma attack” and was then having
nocturnal symptoms and inability to don protective equipment due to respiratory symptoms.
He was issued a P2 profile in November 2001 for alternative physical fitness testing. His
symptoms persisted, he continued to require daily controlled medications and the asthma
condition did not improve adequately with treatment to meet the physical requirements of his
Military Occupational Specialty or satisfy physical fitness standards. In June 2002, he was
issued a permanent P3 profile and referred for a Medical Evaluation Board (MEB). The MEB
identified and forwarded moderate persistent asthma as the only condition for Physical
Evaluation Board (PEB) adjudication. The PEB adjudicated the asthma condition as unfitting,
rated 30%, with application of the Veteran’s Affairs Schedule for Rating Disabilities (VASRD).
The CI was placed on the temporary disability retired list (TDRL) because his condition was not
sufficiently stable for final adjudication. The CI was re-evaluated almost 14 months later and
the PEB recommended removal of the CI from the TDRL with a permanent disability rating of
10%. The CI made no appeals and was medically separated with a 10% disability rating.
CI CONTENTION: “I was originally diagnosed with asthma after returning from Desert
Shield/Storm in 1991. I was able to control the asthma through medication and it did not
impact my ability to deploy. However, in 2001, I began experiencing adverse health effects
while wearing the protective mask and during physical fitness tests due to asthma. I was placed
on a permanent profile and began the medical evaluation board. I was discharged from the
Army Oct, 2002 after 17 years of service and placed on the temporary retired list with a
disability rating of 30%. The VA had also completed its assessment and assigned a disability
rating of 30% as well in November, 2002. The following year, the Army reduced my disability to
10% and removed me from the retired list and changed my status. However, the VA
reassessment in 2005 still resulted in a 30% disability rating. I ask that the DOD reconsider the
10% rating and align to the VA rating.”
SCOPE OF REVIEW: The Board wishes to clarify that the scope of its review as defined in DoDI
6040.44, Enclosure 3, paragraph 5.e.(2) is limited to those conditions which were determined
by the PEB to be specifically unfitting for continued military service; or, when requested by the
CI, those condition(s) “identified but not determined to be unfitting by the PEB.” The ratings
for unfitting conditions will be reviewed in all cases. Any conditions or contention not
requested in this application, or otherwise outside the Board’s defined scope of review, remain
eligible for future consideration by the Army Board for the Correction of Military Records.
PFTs
FEV1 (% Predicted)
FEV1/FVC
Meds
§4.97 Rating
117%
112%
Daily inhaled steroids
Daily inhaled beta agonists
30%(daily inhaled steroids)
93%
82%
Daily inhaled steroids
Inhaled beta agonists as needed
30%(daily inhaled steroids)
TDRL RATING COMPARISON:
Service PEB – Dated 20031022
VA – All Effective Date 20021011
Condition on TDRL entry – 20021011
Asthma
Code
6602
Rating
TDRL
30%
Sep.
10%
Condition
Asthma
Code
6602
Rating
30%*
Exam
20020925
↓No Additional MEB/PEB Entries↓
0% x 4/Not Service Connected x 4
Combined: 10%
Combined: 30%
*30% rating continued after scheduled VA C&P review examination in February 2005.
ANALYSIS SUMMARY: The Board notes the current Department of Veterans’ Affairs (DVA)
ratings listed by the CI for his service-connected condition but must emphasize that its
recommendations are premised on severity at the time of separation. The DVA ratings which it
considers in that regard are those rendered most proximate to separation. The DES has neither
the role nor the authority to compensate service members for anticipated future severity or
potential complications of conditions resulting in medical separation. That role and authority is
granted by Congress to the DVA.
Asthma Condition. There were two pulmonary function tests (PFTs) evaluations in evidence,
with documentation of additional ratable criteria, which the Board weighed in arriving at its
rating recommendation; as summarized in the chart below.
PFTs performed ~4 Mo. Pre-TDRL entry
PFTs performed ~2 Mo. Pre-TDRL exit
Used in NARSUM & VA C&P
Used by PEB at TDRL exit
At the MEB exam performed almost 4 months prior to TDRL entry, the CI reported diagnosed
with asthma symptoms and an asthma attack in 1991. He was taking Serevent, Flovent,
Albuterol and Zyrtec. The MEB physical exam noted normal lung examination.
The initial narrative summary (NARSUM) prepared approximately 3 months prior to TDRL entry
noted the CI’s initial presentation to the pulmonary clinic in November 2001 after experiencing
symptoms consistent with persistent asthma for the previous 10 years. It was noted that his
last visit to the emergency department was approximately ten years prior and that he had a
positive Methacholine challenge test (MCT) in September 1991 (the MCT result primary
document is not available for review). He failed an Army physical fitness test (APFT) due to
exertional symptoms and had no previous difficulty donning respiratory protective equipment.
At the time of presentation to the pulmonary clinic, the CI was using inhaled bronchodilators
and corticosteroid medications on a daily basis. In November 2001, he was issued a P2 profile
for alternate APFT and his asthma condition was monitored. On follow-up in June 2002, the CI
was still requiring daily controller medications, continued to be symptomatic with exertional
activities, experienced an asthma exacerbation during a local field training exercise, admitted to
nocturnal symptoms two to three times a week and was unable to don respiratory protective
equipment presumable due to respiratory symptoms. Physical exam revealed clear lungs. PFT
results, performed 4 months prior to TDRL entry, and medication use are documented in the
chart above.
2 PD1200469
At the VA Compensation and Pension (C&P) exam performed almost a month prior to TDRL
entry prior to separation, documented a history similar to that outlined above with the
following additional information: never required hospitalization for asthma, no need for oral
steroids and treatment with both beta 2 agonists, long and short acting, and inhaled steroids.
Physical examination revealed clear lungs to auscultation. This C&P examination referred to
PFT results obtained on 25 June 2002, the same PFT results referred to in the initial NARSUM.
The TDRL evaluation summary prepared almost 2 months prior to separation documents the
following interval history concerning the 11 month interval spent on TDRL. The CI continued on
the daily medications of Advair (twice daily), Flonase, Zyrtec and Albuterol as needed. The CI
reported symptoms approximately once a month with no nocturnal symptoms and no need for
daily Albuterol use. He had two asthma exacerbations in April 2003 that required only fast
acting Albuterol inhalers with no mention of oral steroid use. Physical exam revealed lungs to
be clear to auscultation bilaterally. PFT data is summarized in the chart above.
The Board directs attention to its rating recommendation based on the above evidence. The
PEB initially utilized VASRD code 6602, asthma, and rated it 30% based on daily inhaled
medications with normal PFTs and placed the CI on TDRL. Three months after TDRL entry, the
VA coded the asthma using 6602 and rated it 30%; citing the same PTF results used by the PEB
at TDRL entry and treatment with beta 2 agonist and short acting inhaled steroids. Fourteen
months after TDRL entry, the PEB reevaluated the CI, making its final adjudication of asthma,
coded 6602, and rated at 10% citing “pharmacy record noting intermittent use of medications
since being placed on TDRL.” The rating criteria for VASRD code 6602 rely on evaluation of the
PFTs, the frequency of medication use, physician visits and asthma exacerbations. The 10%
rating requires an FEV-1 of 71- to 80% predicted or; FEV-1/FVC of 71 to 80% or; intermittent
inhalational or oral bronchodilator therapy and is the rating given by the PEB’s final
adjudication. This PEB rating was specifically based on the lack of documentation concerning
the CI’s daily use of inhaled medications. Both the NARSUM and the TDRL re-evaluation
summary document PFT results that were above compensable levels and therefore the rating
recommendation in this case is to be based entirely on medication use. The records present for
review document that daily inhaled steroids were consistently recommended by the medical
providers and the CI consistently reported using them as recommended. The medication
profile is the key information required to justify a 30% rating in this case, as the intermittent
inhalational bronchodilator medication use required for a 10% rating is easily met. The criteria
for the next higher rating, 30%, include “daily inhalational or oral bronchodilator therapy, or;
inhalational anti-inflammatory medication.” Any frequency of use of inhalational anti-
inflammatory medication satisfies the rating criteria and the pharmacy records are compatible
with either a once daily dosing regimen or an intermittent twice-daily dosing regimen. After
due deliberation, considering all of the evidence and mindful of VASRD §4.3 (reasonable doubt),
the Board recommends a permanent disability rating of 30% for the asthma condition.
BOARD FINDINGS: IAW DoDI 6040.44, provisions of DoD or Military Department regulations or
guidelines relied upon by the PEB will not be considered by the Board to the extent they were
inconsistent with the VASRD in effect at the time of the adjudication. The Board did not
surmise from the record or PEB ruling in this case that any prerogatives outside the VASRD
were exercised. In the matter of the asthma condition, the Board unanimously recommends a
30% permanent disability rating, coded 6602 IAW VASRD §4.97. There were no other
conditions within the Board’s scope of review for consideration.
3 PD1200469
RECOMMENDATION: The Board recommends that the CI’s prior determination be modified as
to reflect a permanent combined 30% disability retirement upon removal from the TDRL as
below:
UNFITTING CONDITION
VASRD CODE
RATING
PERMANENT
6602
COMBINED
30%
30%
Asthma
The following documentary evidence was considered:
Exhibit A. DD Form 294, dated 20120604, w/atchs
Exhibit B. Service Treatment Record
Exhibit C. Department of Veterans’ Affairs Treatment Record
XXXXXXXXXXXXXXXX
President
Physical Disability Board of Review
4 PD1200469
a. Providing a correction to the individual’s separation document showing that the
SFMR-RB
MEMORANDUM FOR Commander, US Army Physical Disability Agency
(TAPD-ZB / ), 2900 Crystal Drive, Suite 300, Arlington, VA 22202-3557
SUBJECT: Department of Defense Physical Disability Board of Review Recommendation
for XXXXXXXXXXXXXXXXXXXXX, AR20120021426 (PD201200469)
1. Under the authority of Title 10, United States Code, section 1554(a), I approve the enclosed
recommendation of the Department of Defense Physical Disability Board of Review (DoD PDBR)
pertaining to the individual named in the subject line above to recharacterize the individual’s
separation as a permanent disability retirement with the combined disability rating of 30%
effective the date of the individual’s original medical separation for disability with severance
pay.
2. I direct that all the Department of the Army records of the individual concerned be corrected
accordingly no later than 120 days from the date of this memorandum:
individual was separated by reason of permanent disability retirement effective the date of the
original medical separation for disability with severance pay.
effective the date of the original medical separation for disability with severance pay.
c. Adjusting pay and allowances accordingly. Pay and allowance adjustment will
account for recoupment of severance pay, and payment of permanent retired pay at 30%
effective the date of the original medical separation for disability with severance pay.
medical TRICARE retiree options.
3. I request that a copy of the corrections and any related correspondence be provided to the
individual concerned, counsel (if any), any Members of Congress who have shown interest, and
to the Army Review Boards Agency with a copy of this memorandum without enclosures.
BY ORDER OF THE SECRETARY OF THE ARMY:
Encl
CF:
( ) DoD PDBR
( ) DVA
b. Providing orders showing that the individual was retired with permanent disability
d. Affording the individual the opportunity to elect Survivor Benefit Plan (SBP) and
XXXXXXXXXXXXXXXXXXXXX
Deputy Assistant Secretary
(Army Review Boards)
5 PD1200469
6 PD1200469
AF | PDBR | CY2012 | PD2012-00894
RECORD OF PROCEEDINGS PHYSICAL DISABILITY BOARD OF REVIEW BRANCH OF SERVICE: ARMY SEPARATION DATE: 20030612 NAME: XXXXXXXXXXXXXXXX CASE NUMBER: PD1200894 BOARD DATE: 20130124 SUMMARY OF CASE: Data extracted from the available evidence of record reflects that this covered individual (CI) was an active duty Soldier, SGT/E-5(77F/Fuel Handler), medically separated for an asthma condition. Any conditions or contention not requested in this application, or otherwise outside the Board’s defined...
AF | PDBR | CY2012 | PD2012 01210
No other conditions were submitted by the MEB.The PEB adjudicated asthma with VCDand chronic pain left knee conditions as unfitting, rated 30% and 0% respectively,referencing the US Army Physical Disability Agency (USAPDA) pain policy. 660230%10%Asthma with Vocal Cord Dysfunction660230%20020606Chronic Pain, Left Knee In addition, the CI had a VCD that significantly responded to the beta-agonist inhalational medication, Albuterol for which the medication profile in evidence reflects dosing...
AF | PDBR | CY2011 | PD 2011 01084
TDRL Rating Chart Final Service IPEB Dated 20021001 VA All Effective Date 20030911 Condition Code Rating Condition Code Rating Exam On TDRL 20010813 TDRL Sep. Asthma 6602 30% 0% Asthma 6602 30%* 20031023 .No Additional MEB/PEB Entries. The PEB rated the condition as 6602 asthma, bronchial and assigned a 30% disability stating the asthma condition was only moderately controlled on multiple medications, including daily inhaled anti-inflammatory aerosols. RECOMMENDATION: The Board...
AF | PDBR | CY2014 | PD-2014-03148
Both the Air Force PEB and the VA coded the pulmonary condition 6602 (Asthma). The PEB rated it 10%, and the VA rated it 30%. Eight months later, she was using the anti-inflammatory corticosteroid Motametasone.Following a thorough review of the evidence in the treatment record, the Board concluded that it was more likely than not that the CI was using inhalational anti-inflammatory medication at the time of separation from service.
AF | PDBR | CY2013 | PD-2013-01602
DATE OF PLACEMENT ON TDRL: 20030706Date of Permanent SEPARATION: 20040720 BOARD FINDINGS : IAW DoDI 6040.44, provisions of DoD or Military Department regulations or guidelines relied upon by the PEB will not be considered by the Board to the extent they were inconsistent with the VASRD in effect at the time of the adjudication.The Board did not surmise from the record or PEB ruling in this case that any prerogatives outside the VASRD were exercised.In the matter of the asthma condition and...
AF | PDBR | CY2013 | PD2013 01313
After due deliberation, considering all of the evidence and mindful of VASRD §4.3 (reasonable doubt), the Board recommends no change in the TDRL-entry rating of 30%, and a rating of 30% for the asthma condition at the time of permanent separation. BOARD FINDINGS : IAW DoDI 6040.44, provisions of DoD or Military Department regulations or guidelines relied upon by the PEB will not be considered by the Board to the extent they were inconsistent with the VASRD in effect at the time of the...
AF | PDBR | CY2012 | PD 2012 00734
Post-Separation) Effective 20020807 Condition Code Rating Condition Code Rating Exam Asthma 6602 10% Asthma 6602 10%* 20030114 .No Additional MEB/PEB Entries. Both the Army PEB and the VA coded the asthma condition 6602, and rated it 10%. RECOMMENDATION: The Board, therefore, recommends that there be no recharacterization of the CIs disability and separation determination, as follows: UNFITTING CONDITION VASRD CODE RATING Asthma 6602 10% COMBINED 10% The following documentary evidence...
AF | PDBR | CY2013 | PD-2013-01775
The commander’s letter reflected that the CI’s medical condition of asthma wouldpreclude him from further military service in a field situation.Although absent any VA C&P examination, a subsequent VARD indicated not service-connected (NSC) for a respiratory condition noting “…fail to show any follow-ups for your respiratory symptoms.” BOARD FINDINGS : IAW DoDI 6040.44, provisions of DoD or Military Department regulations or guidelines relied upon by the PEB will not be considered by the...
AF | PDBR | CY2013 | PD-2013-02236
In December 2004 theMEB found the asthma condition had stabilized sufficiently and the PEB adjudicated “exertion asthma” unfitting, rated at 10% disability and the CI was removed from the TDRL on 30 December 2004. The Board deliberated if the TDRL NARSUM current medications’listing oral Singulair was supported by the record and if it met the VASRD 6602 30% rating criteria for daily oral bronchodilator therapy.The Board discussed the evidence of record concerning Singulair use.Singulair was...
AF | PDBR | CY2013 | PD-2013-01964
The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of theVeterans Affairs Schedule for Rating Disabilities (VASRD) standards to the unfitting medical condition at the time of separation. He requires close medical follow-up, and consideration should be given to TDRL status.”On 4 January 2004, the CI was placed on the TDRL with a rating of 60%. The CI’s asthma was not severe enough to justify a higher...